中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2014年
5期
593-596
,共4页
穆鑫%赵颖%阿丽塔%李阳%王昕%唐小利%杜冠华
穆鑫%趙穎%阿麗塔%李暘%王昕%唐小利%杜冠華
목흠%조영%아려탑%리양%왕흔%당소리%두관화
药理学%学科发展%国际论文%研究机构分析%研究领域分析%研究现状
藥理學%學科髮展%國際論文%研究機構分析%研究領域分析%研究現狀
약이학%학과발전%국제논문%연구궤구분석%연구영역분석%연구현상
pharmacology%discipline development%internation-al papers%research institution analysis%research area analysis%research status
为了解2013年中国药理学发展的特点,本文对中国学者2013年发表的国际论文进行研究,以期帮助科研人员了解该领域最新进展。本研究在2012版期刊引证报告自然科学版药理学期刊中,检索2013年中国学者发文情况。结果显示,2013年中国作者共参与发表文献5090篇,其中,中国作者为第一/通讯作者的文献4812篇,期刊影响因子最高为22.345。发文涉及的研究机构大多为大学和高校,科研院所及临床医院较少。从发表文章的数量上看,植物药研究在我国研究人员研究领域中占有重要地位,研究热点比较分散。结果提示,2013年我国药理学研究正处于发展的重要阶段,基础研究需要积累和创新,临床药理学和新药研究亟待加强。
為瞭解2013年中國藥理學髮展的特點,本文對中國學者2013年髮錶的國際論文進行研究,以期幫助科研人員瞭解該領域最新進展。本研究在2012版期刊引證報告自然科學版藥理學期刊中,檢索2013年中國學者髮文情況。結果顯示,2013年中國作者共參與髮錶文獻5090篇,其中,中國作者為第一/通訊作者的文獻4812篇,期刊影響因子最高為22.345。髮文涉及的研究機構大多為大學和高校,科研院所及臨床醫院較少。從髮錶文章的數量上看,植物藥研究在我國研究人員研究領域中佔有重要地位,研究熱點比較分散。結果提示,2013年我國藥理學研究正處于髮展的重要階段,基礎研究需要積纍和創新,臨床藥理學和新藥研究亟待加彊。
위료해2013년중국약이학발전적특점,본문대중국학자2013년발표적국제논문진행연구,이기방조과연인원료해해영역최신진전。본연구재2012판기간인증보고자연과학판약이학기간중,검색2013년중국학자발문정황。결과현시,2013년중국작자공삼여발표문헌5090편,기중,중국작자위제일/통신작자적문헌4812편,기간영향인자최고위22.345。발문섭급적연구궤구대다위대학화고교,과연원소급림상의원교소。종발표문장적수량상간,식물약연구재아국연구인원연구영역중점유중요지위,연구열점비교분산。결과제시,2013년아국약이학연구정처우발전적중요계단,기출연구수요적루화창신,림상약이학화신약연구극대가강。
Aim To investigate the characteristics of research status of pharmacology in China and help Chinese scientists have a good look at latest development in this field, by analyzing the articles published in international journals in 2013. Methods Articles with Chinese authors published in pharmacology related international journals originating from the 2012 edition of natural science edition of Journal Citation Reports were retrieved. Re-sults There were 5090 articles with Chinese authors published in 2013, including 4812 articles whose Chinese authors were the first author or corresponding author. Among them, the highest impact factor was 22. 345. Universities and colleges were the main organizations in paper publishment in China. The number of articles from research institutes and hospitals was much lower. Herbal medicine occupied a very important position in Chinese pharmacological research, while the research hotspot was scat-tered. Conclusion In 2013, the pharmacological research in China is at an important stage of development. A long continuous accumulation of summary and innovation is needed in basic re-search. More studies should focus on clinical pharmacology and drug discovery.